Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention (Q37789688)

23 August 2017

title

Thrombosis and inflammatory bowel disease: a call for improved awareness and prevention (English)

1 reference

inflammatory bowel diseases

23 August 2017

main subject

0 references

0 references

0 references

Naamah L Zitomersky

1

1 reference

23 August 2017

Menno Verhave

series ordinal

2

1 reference

23 August 2017

Cameron C Trenor

series ordinal

3

1 reference

23 August 2017

publication date

1 January 2011

1 reference

Inflammatory Bowel Diseases

23 August 2017

published in

1 reference

23 August 2017

volume

17

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

458-470

1 reference

Venous thrombosis: a multicausal disease

23 August 2017

cites work

1 reference

Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease

21 January 2018

1 reference

Circulating von Willebrand factor in inflammatory bowel disease

21 January 2018

1 reference

Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces

21 January 2018

1 reference

The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia

21 January 2018

1 reference

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

Formation of platelet-leukocyte aggregates in inflammatory bowel disease

21 January 2018

1 reference

Thromboembolism in inflammatory bowel disease: role of platelets

21 January 2018

1 reference

Risk factors for thromboembolic complications in inflammatory bowel disease: the role of hyperhomocysteinaemia

21 January 2018

1 reference

Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study

21 January 2018

1 reference

The incidence of arterial thromboembolic diseases in inflammatory bowel disease: a population-based study

21 January 2018

1 reference

Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

21 January 2018

1 reference

Venous thromboembolism in inflammatory bowel disease

21 January 2018

1 reference

Cerebral and retinal vascular complications of inflammatory bowel disease

21 January 2018

1 reference

Cerebral venous thrombosis in acute inflammatory bowel disease

21 January 2018

1 reference

Increased carotid intima-media thickness in patients with inflammatory bowel disease

21 January 2018

1 reference

Fibrinogen and risk of cardiovascular disease. The Framingham Study.

21 January 2018

1 reference

Blood rheology in arterial disease

21 January 2018

1 reference

Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides

21 January 2018

1 reference

Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors

21 January 2018

1 reference

Lack of Effect of Prednisone Administration on Bleeding Time and Platelet Function of Normal Subjects

21 January 2018

1 reference

Inhibition of prostaglandin synthesis by glucocorticoids in human endothelial cells

21 January 2018

1 reference

Corticosteroids: do they damage the cardiovascular system?

21 January 2018

1 reference

Inflammation and coagulation in inflammatory bowel disease: The clot thickens

21 January 2018

1 reference

Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease.

21 January 2018

1 reference

Azathioprine-induced warfarin resistance

21 January 2018

1 reference

Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine

21 January 2018

1 reference

Thromboembolic complications and haemostatic changes in cyclosporin-treated cadaveric kidney allograft recipients

21 January 2018

1 reference

Cerebral sinus thrombosis associated with severe active ulcerative colitis

21 January 2018

1 reference

Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study

21 January 2018

1 reference

TNF-mediated inflammatory disease.

21 January 2018

1 reference

Safety of infliximab and other biologic agents in the inflammatory bowel diseases

21 January 2018

1 reference

Factor V Leiden mutation is not increased in patients with inflammatory bowel disease.

21 January 2018

1 reference

A comprehensive analysis of 12 thrombophilic mutations and related parameters in patients with inflammatory bowel disease: data from Turkey

21 January 2018

1 reference

The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

21 January 2018

1 reference

Magnetic resonance venography in assessing venous patency after multiple venous catheters.

21 January 2018

1 reference

Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate.

21 January 2018

1 reference

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

21 January 2018

1 reference

Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients

21 January 2018

1 reference

Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)

21 January 2018

1 reference

Inherited disorders of coagulation appear to protect against inflammatory bowel disease

21 January 2018

1 reference

Treatment of corticosteroid-resistant ulcerative colitis with heparin--a report of 16 cases.

21 January 2018

1 reference

Low molecular weight heparin as adjuvant therapy in active ulcerative colitis

21 January 2018

1 reference

Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial

21 January 2018

1 reference

Low molecular weight heparin (tinzaparin) vs. placebo in the treatment of mild to moderately active ulcerative colitis.

21 January 2018

1 reference

Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study

21 January 2018

1 reference

Randomized, placebo-controlled trial of low molecular weight heparin in active ulcerative colitis.

21 January 2018

1 reference

Meta-analysis: The utility and safety of heparin in the treatment of active ulcerative colitis.

21 January 2018

1 reference

Heparin, cell adhesion, and pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

Oral, colonic-release low-molecular-weight heparin: an initial open study of Parnaparin-MMX for the treatment of mild-to-moderate left-sided ulcerative colitis.

21 January 2018

1 reference

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.21334

1 reference

23 August 2017

1 reference